Logo

OncoCyte

EchelonDx, Oncocyte to Develop Software Supporting Commercial Diagnostics Expansion

The two firms are developing an analytical software solution to help Oncocyte scale its commercial oncology test business to a global scale.

Oncocyte Inks At-Market Agreement to Sell Up to $50M in Stock

The company said any proceeds raised will help continue commercialization of its lead test, DetermaRx, and fund the development of the rest of its pipeline.

Oncocyte, Italian Foundation to Investigate DetermaIO in Colorectal Cancer

The Italian research group will evaluate the ability of Oncocyte's gene expression assay in samples from immunotherapy trials for advanced colorectal cancer patients.

Oncocyte Posts $1.1M in Q1 Revenues, Beating Wall Street Expectations

The firm's first quarter revenue growth was driven by sales of its DetermaRx lung cancer recurrence risk test and growth in its pharma services business.

Oncocyte AACR Data Expands Potential Applications for Immunotherapy Response Predictor

The firm presented evidence that its DetermaIO gene expression test can help predict which bladder cancer patients are likely to respond to immune checkpoint inhibitors.

Mar 18, 2021

Oncocyte Details New Expansions Plans With Growing Portfolio of Acquired Tests
Premium

Mar 16, 2021

Oncocyte Posts $503K in Q4 Revenues, Misses Wall Street Expectations

Mar 12, 2021

People in the News: New Appointments at Oncocyte, Ontera, Agilent, More

Feb 25, 2021

Oncocyte Closes Second and Final Investment in Razor Genomics Acquisition

Feb 5, 2021

Oncocyte to Raise $35M in Public Stock Offering

Feb 2, 2021

Oncocyte to Acquire Chronix Biomedical

Jan 20, 2021

Oncocyte to Raise $25M in Stock Sale to Institutional Investors

Dec 16, 2020

Piper Sandler Raises Rating on Oncocyte to Overweight

Dec 15, 2020

Burning Rock Biotech Licenses Oncocyte Lung Cancer Assay

Nov 30, 2020

BTIG Initiates Coverage of Oncocyte With Buy Rating

Nov 12, 2020

OncoCyte Posts $555K in Q3 Revenues, Net Loss Rises

Oct 21, 2020

Oncocyte DetermaRx Predicts Early Lung Cancer Outcomes Regardless of EGFR Status
Premium

Oct 8, 2020

Oncocyte, Fondazione Michelangelo to Evaluate DetermaIO Test for Immunotherapy Response Prediction

Oct 2, 2020

In Brief This Week: Illumina, BGI, Thermo Fisher, Genetron, Yourgene, Caris Life Sciences, More

Oct 1, 2020

Oncocyte, Chronix Enter Licensing, Collaboration Agreement for Liquid Biopsy Technology

Sep 3, 2020

Oncocyte, Guardian Research Network Partner to Improve Precision Medicine Clinical Trials

Jul 30, 2020

Oncocyte Provides Post-Mortem on DetermaDx Failure, Describes Renewed Focus on Remaining Assays
Premium

Jul 29, 2020

OncoCyte Q2 Net Loss Ticks Up

Jul 16, 2020

ProGenetics to Distribute Oncocyte Lung Cancer Test in Israel

Jul 15, 2020

Noridian Providing Limited Coverage for MDx Tests as Predictive Classifiers for NSCLC

Breaking News
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.